Project Grant HT94252510957
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $320K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- This Project Grant award of $999,983.00 from the Defense Health Agency supports research by The Leland Stanford Junior University (Stanford University) to analyze Epstein-Barr virus (EBV) genomes, epigenomes, and EBV-dependent B cell proteomes. The goal is to identify fundamental viral triggers of multiple sclerosis (MS). The 3-year project will run from July 1, 2023 to June 30, 2026. This award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports...
- The U.S. Department of Defense's Defense Health Agency awarded a $250,000 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "EPSTEIN-BARR VIRUS IN PATIENTS WITH NEW-ONSET MULTIPLE SCLEROSIS". The project will run from July 1, 2024 to June 30, 2026. As a prime grantee, Yale University will lead this scientific research effort to advance knowledge about the relationship between Epstein-Barr virus and the...
- This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
- This $2,291,595 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a longitudinal study to determine whether Epstein-Barr virus (EBV)-induced molecular mimicry is a likely cause of multiple sclerosis (MS) in African Americans. The award will fund a study using blood samples collected from over 10 million active duty U.S. military personnel to investigate the relationship...
- This $427,627 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to The University of Iowa supports research on the impact of gamma herpesvirus, specifically Epstein-Barr virus (EBV), on the interactions between B cells and CD4 T cells in a mouse model of multiple sclerosis (MS). The research aims to understand how EBV infection may influence the development of autoimmunity and neuroinflammation in MS, a...
- This $249,241 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Queensland in Australia. The research aims to investigate how Epstein-Barr virus (EBV) infection at different ages impacts the development of central nervous system (CNS) demyelinating diseases using a novel humanized mouse model. The two-year project will be conducted from August 2024 to August 2026 to advance...
- The Department of the Army Medical Command awarded a $755,250 Project Grant to The Ohio State University Office of Sponsored Programs through the Military Medical Research and Development federal grant program. The three-year award beginning September 30, 2022 will fund research to define the genetic basis and pathologic network of post-traumatic epilepsy using Collaborative Cross mice. As part of the Military Medical Research and Development program's goals to transform military and public...
- The U.S. Defense Health Agency awarded a $999,006 Project Grant to The Wistar Institute of Anatomy and Biology in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will fund research on Epstein-Barr virus-driven B-cell inflammation and central nervous system trafficking in multiple sclerosis. The Wistar Institute has previously served as a subcontractor on federal grants, providing...
- This $250,000 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research into TRNA-derived RNA fragments and their potential role in mediating multiple sclerosis associated with Epstein-Barr virus. The award, made on November 1, 2025, will support this research to be conducted by the University of Texas Medical Branch at Galveston over a one-year period, with a planned completion date of October 31,...
- The U.S. Defense Health Agency awarded a $250,000 Project Grant on July 1, 2023 to The Leland Stanford Junior University, also known as Stanford University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports the isolation and engineering of potent anti-EBV neutralizing antibodies for the treatment of multiple sclerosis (MS). The project will be conducted at Stanford University's campus in Stanford, California over a 2-year period, ending on June 30,...